✦ LIBER ✦

Chemoprevention of intestinal polyposis in the APCΔ716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor

✍ Scribed by Jilly F Evans; Masanobu Oshima; Naomi Murai; Stacia Kargman; Metzli Arguello; Pauline Luk; Elizabeth Kwong; Makoto M Taketo

Book ID: 119389554
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 36 KB
Volume: 95
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(00)01572-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoprevention of intestinal polyposis

Chemoprevention of intestinal polyposis by COX-2 inhibition: From mouse to man: Ohshima M. Murai (Hata) N, Kargama S, Aguello M, Luk P, Kwong E, Taketo M, Evans JF (Banyu-Merck Research Center, Tsukuba, Japan; Merck Frosst Center for Therapeutic Research, Pointe-Claire Dorval, Quebec, Canada; University of Kyoto, Tokyo, Japan; and Merck and Co., Inc., West Point, Pennsylvania). Chemoprevention of intestinal polyposis in the Apcδ716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 2001;61:1733–1740

✍ Robert S. Bresalier 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 353 KB

Suppression of Intestinal Polyposis in A

Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

✍ Masanobu Oshima; Joseph E Dinchuk; Stacia L Kargman; Hiroko Oshima; Bruno Hancoc 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 1000 KB

Analgesic efficacy of the cyclooxygenase

Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: A randomized, controlled trial

✍ Briggs W. Morrison; Steven Christensen; Weiying Yuan; Jean Brown; Susan Amlani; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 724 KB

COX189 (PrexigeTM), a novel, selective c

COX189 (PrexigeTM), a novel, selective cyclooxygenase-2 inhibitor, totally inhibits formation of intestinal polyps in C57BL/6J-APCmin mouse model of human adenomatous polyposis coli, and reduces neovascularization in vivo

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Rofecoxib, a specific inhibitor of cyclo

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

✍ Grant W. Cannon; Jacques R. Caldwell; Peter Holt; Barry McLean; Beth Seidenberg; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 3 views

Significant growth inhibition of human l

Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a cyclooxygenase 2-specific inhibitor, JTE-522, and conventional anticancer agents

✍ Toyoaki Hida; Ken-Ichi Kozaki; Hidemi Ito; Osamu Miyaishi; Yoshio Tatematsu; Tak 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 101 KB